Published guidance, NICE advice and quality standards | Guidance

Showing 761 to 770 of 881

Sort by

Published guidance, NICE advice and quality standards
Title	Reference number	Published	Last updated
Loxapine inhalation for treating acute agitation and disturbed behaviours associated with schizophrenia and bipolar disorder (terminated appraisal)	TA286	22 May 2013	22 May 2013
Omalizumab for treating severe persistent allergic asthma	TA278	24 April 2013	24 April 2013
Percutaneous vertebroplasty and percutaneous balloon kyphoplasty for treating osteoporotic vertebral compression fractures	TA279	24 April 2013	24 April 2013
Colistimethate sodium and tobramycin dry powders for inhalation for treating pseudomonas lung infection in cystic fibrosis	TA276	27 March 2013	27 March 2013
Methylnaltrexone for treating opioid-induced bowel dysfunction in people with advanced illness receiving palliative care (terminated appraisal)	TA277	27 March 2013	27 March 2013
Tadalafil for the treatment of symptoms associated with benign prostatic hyperplasia (terminated appraisal)	TA273	23 January 2013	23 January 2013
Vinflunine for the treatment of advanced or metastatic transitional cell carcinoma of the urothelial tract	TA272	23 January 2013	23 January 2013
Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma	TA268	12 December 2012	12 December 2012
Decitabine for the treatment of acute myeloid leukaemia (terminated appraisal)	TA270	12 December 2012	12 December 2012
Dronedarone for the treatment of non-permanent atrial fibrillation	TA197	25 August 2010	1 December 2012